Search results for abx831459

Cusatuzumab, Abbexa, abx831459

Cusatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD70/TNFSF7, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Cusatuzumab is an experimental SIMPLE antibody that targets CD70, which is an immune checkpoint target involving hematological malignancies, a variety of solid tumors, and a variety of autoimmune diseases. Cusatuzumab aims to block CD70 by targeting complement-dependent cytotoxicity, enhancing antibody-dependent cell-mediated phagocytosis, and enhancing antibody-dependent cell-mediated cytotoxicity, killing CD70-expressing cancer cells, and recovering Immune monitoring of solid tumors.